Lemaitre Vascular (LMAT) Tops Q1 EPS by 1c

Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $35.9 million versus the consensus estimate of $35.2 million.

GUIDANCE:

Lemaitre Vascular sees Q2 2021 EPS of $0.28-$0.36, versus the consensus of $0.28. Lemaitre Vascular sees Q2 2021 revenue of $37-40 million, versus the consensus of $35.9 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• Is Treasury selloff a major issue for stock market bulls?